Narrative review indicates lithium affects inhibitory control in executive tasks, suggesting cognitive implications for patients.
Objective: Lithium counteracts impulsivity and aggression in affective disorders, two emotion-related facets of inhibitory control. This raises the question of whether lithium also affects inhibitory processes in the cognitive domain. Methods: This narrative review examines experimental groups of patients receiving lithium, either as monotherapy or as part of multitherapy, compared with patients on other medications or healthy controls. Results: Patients taking lithium alongside other medications performed worse than healthy controls on the Trail Making Test B, Stroop Color-Word Test, and Wisconsin Card Sorting Test. Similarly, those on lithium monotherapy also underperformed compared to healthy controls on the Trail Making Test B and Stroop Color-Word Test. However, their performance on the Wisconsin Card Sorting Test was less impaired. Discussion: The inhibitory processes assessed by the Trail Making Test B and Stroop Color-Word Test appear to be particularly susceptible to the effects of lithium. Conclusion: The apparent vulnerability in performance on the Trail Making Test B and Stroop tests needs to be confirmed with studies that include placebo controls.
No takes yet. Share an insight, caveat, or question.
Lalonde et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: